Login

ST JUDE MEDICAL, LLC

No Longer Reporting

The company has not filed an annual or quarterly report since its Q3 FY2016 10-Q, filed Nov 7, 2016. Its latest SEC filing is a 425 from Mar 7, 2017.

The sections below describe the company as of the FY2015 annual report.

How Did They Make Money?

FY2016 revenue

Did Revenues Turn Into Profits?

Yes. It kept 16 cents of every revenue dollar as net income in FY2016 and turned 15 cents into free cash flow.

Operating income, FY2016
19% of revenue
▼ −11% vs FY2015 ($1.2B, 20%)
Net income, FY2016
16% of revenue
▼ −12% vs FY2015 ($1B, 18%)
Free cash flow, FY2016
15% of revenue
▼ −23% vs FY2015 ($1.1B, 20%)

How Were They Changing?

Since the FY2015 annual report
Latest quarter: Q3 FY2016, the three months to Oct 1, 2016
Revenue
▲ +12%
vs $1.3B in Q3 FY2015
Net income
▼ −1%
vs $215M in Q3 FY2015

Held flat. Revenue was $5.5B in FY2016, about the same as the $5.6B of FY2015.

Revenue over time
ICD Systems Atrial Fibrillation Products Pacemaker Systems Vascular Products Structural Heart Products Neuromodulation Products Thoratec Products
$10B$5B$0

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support